0001493152-20-006344.txt : 20200414 0001493152-20-006344.hdr.sgml : 20200414 20200414142832 ACCESSION NUMBER: 0001493152-20-006344 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200414 DATE AS OF CHANGE: 20200414 EFFECTIVENESS DATE: 20200414 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Akers Biosciences, Inc. CENTRAL INDEX KEY: 0001321834 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 000000000 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-364932 FILM NUMBER: 20791054 BUSINESS ADDRESS: STREET 1: 201 GROVE RD CITY: THOROFARE STATE: NJ ZIP: 08086 BUSINESS PHONE: 856-848-8698 MAIL ADDRESS: STREET 1: 201 GROVE RD CITY: THOROFARE STATE: NJ ZIP: 08086 FORMER COMPANY: FORMER CONFORMED NAME: Akers Biosciences Inc DATE OF NAME CHANGE: 20050325 D 1 primary_doc.xml X0708 D LIVE 0001321834 Akers Biosciences, Inc. 201 GROVE ROAD THOROFARE NJ NEW JERSEY 08086 (856) 848-8698 NEW JERSEY None Akers Biosciences Inc Corporation true Howard Yeaton 201 Grove Road Thorofare NJ NEW JERSEY 08086 Executive Officer Interim Chief Financial Officer Christopher C. Schreiber 201 Grove Road Thorofare NJ NEW JERSEY 08086 Executive Officer Director Executive Chairman of the Board of Directors; Principal Executive Officer Joshua Silverman 201 Grove Road Thorofare NJ NEW JERSEY 08086 Director Bill J. White 201 Grove Road Thorofare NJ NEW JERSEY 08086 Director Robert C. Schroeder 201 Grove Road Thorofare NJ NEW JERSEY 08086 Director Other Health Care Decline to Disclose 06b false 2020-04-08 false true true false 0 459998 459998 0 Represents the issuance to the placement agent of warrants to purchase up to 61,333 shares of common stock at an exercise price of $7.50/share in connection with a registered offering of common stock that closed on April 8, 2020. false 1 0 0 0 false Akers Biosciences, Inc. /s/ Howard Yeaton Howard Yeaton Interim Chief Financial Officer 2020-04-14